Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering

Friday, March 13, 2026 · indivior plc

AI Briefing

Indivior Pharmaceuticals upsized its convertible senior notes offering to $450M, from $400M, and granted initial purchasers a 30-day option to buy up to $50M more.
The offering is for 0.625% convertible senior notes due 2031.
The sale of the notes is expected to settle on March 17, 2026, subject to customary closing conditions.